SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.

N'Guessan, Kombo F; Patel, Priyankaben H; Qi, Xiaoyang

N'Guessan, Kombo F; Patel, Priyankaben H; Qi, Xiaoyang.

Affiliation

N'Guessan KF; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Patel PH; Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Qi X; Department of Biomedical Sciences, University of Cincinnati, Cincinnati, OH, USA.

Cell Commun Signal ; 18(1): 6, 2020 01 09.

Article in En | MEDLINE | ID: mdl-31918715

Subject(s)

Nanoparticles/chemistry; Neoplasms/therapy; Phosphatidylserines/metabolism; Saposins/metabolism; Animals; Clinical Trials as Topic; Humans

Key words

Brain tumor; Flippase; Lung cancer; Pancreatic cancer; Phosphatidylserine; SapC-DOPS

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phosphatidylserines / Saposins / Nanoparticles / Neoplasms Limits: Animals / Humans Language: En Journal: Cell Commun Signal Year: 2020 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google